Adalimumab use in pregnancy

被引:98
作者
Vesga, L [1 ]
Terdiman, JP [1 ]
Mahadevan, U [1 ]
机构
[1] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94115 USA
关键词
D O I
10.1136/gut.2005.065417
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:890 / 890
页数:1
相关论文
共 8 条
[1]   Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[2]   A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease [J].
Hanauer, S ;
Lukás, M ;
MacIntosh, D ;
Rutgeerts, P ;
Sandborn, W ;
Pollack, P .
GASTROENTEROLOGY, 2004, 127 (01) :332-332
[3]   Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549
[4]   Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis [J].
Katz, JA ;
Antoni, C ;
Keenan, GE ;
Smith, DE ;
Jacobs, SJ ;
Lichtenstein, GR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2385-2392
[5]  
MAHADEVAN U, 2005, IN PRESS ALIMENT THE
[6]  
Sandborn WJ, 2004, GASTROENTEROLOGY, V126, pA53
[7]   A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease [J].
Targan, SR ;
Hanauer, SB ;
vanDeventer, SJH ;
Mayer, L ;
Present, DH ;
Braakman, T ;
DeWoody, KL ;
Schaible, TF ;
Rutgeerts, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) :1029-1035
[8]   Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFα monoclonal antibody [J].
Treacy, G .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2000, 19 (04) :226-228